Cognition Therapeutics, Inc.
CGTX
$1.20
$0.021.70%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 30.86% | 18.34% | -6.15% | -15.76% | -31.73% |
| Total Depreciation and Amortization | -14.29% | -8.81% | -3.52% | 1.20% | 5.56% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -46.03% | -49.49% | -43.35% | -30.22% | -15.60% |
| Change in Net Operating Assets | -368.40% | -201.68% | -118.83% | -135.69% | -73.42% |
| Cash from Operations | 13.65% | -15.60% | -34.45% | -51.32% | -77.76% |
| Capital Expenditure | -- | 96.97% | 98.90% | 96.23% | 97.28% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 325.00% | 96.97% | 98.90% | 96.23% | 97.28% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 52.23% | 34.44% | 17.93% | 13.17% | 8.88% |
| Issuance of Common Stock | 48.00% | 202.27% | -7.63% | -9.49% | 398.42% |
| Repurchase of Common Stock | 82.61% | 90.77% | -576.56% | -733.02% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -68.92% | -- | 100.00% | -- | -- |
| Cash from Financing | 55.19% | 223.78% | -3.73% | -22.13% | 421.23% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 344.07% | 262.55% | -96.10% | -340.76% | 57.79% |